[Diffusion of cefpirome in ascitic fluid].
Taugourdeau
M C
MC
Laurent-Puig
P
P
Hagège
H
H
Taburet
A M
AM
Etienne
J P
JP
Singlas
E
E
D000328:Adult; D001202:Ascitic Fluid / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D002511:Cephalosporins / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004058:Diffusion; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D006801:Humans; D007275:Injections, Intravenous; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D008875:Middle Aged; D000097572:Cefpirome
D002511:Cephalosporins; D000097572:Cefpirome
Diffusion de la cefpirome dans le liquide d'ascite.